other material
confidence high
sentiment neutral
materiality 0.55
Xilio Therapeutics stockholders approve reverse stock split at ratio from 1:2 to 1:30
Xilio Therapeutics, Inc.
- Stockholders approved reverse stock split at ratio between 1:2 and 1:30, board to set exact ratio and timing.
- Proposal passed with 55,438,144 votes for, 1,521,271 against, 33,539 abstaining, no broker non-votes.
- Adjournment proposal also approved with 55,461,067 for, 1,491,733 against, 40,154 abstaining.
- Special meeting held on February 23, 2026; both proposals received overwhelming stockholder support.